[2][3] Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023.

[7] In 1887, Otto Schott developed borosilicate glass, a form of glassware used to reagent bottles and flasks.

From 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials.

[10][11] In the same year, the company announced their plans to present an IPO, but this was reportedly postponed to 2023 due to the Russian invasion of Ukraine.

[12] This plan was enacted in September, with Schott Pharma going public on the Frankfurt Stock Exchange.